|
|
|
Second Sight Medical Products Inc. 
|
1.71 -0.05 (-0.03%) |
01-15 16:00 |
Open: |
1.75 |
Pre close: |
1.76 |
Target:
|
3.67
|
High: |
1.77 |
Low: |
1.66 |
Resistance:
|
3.15
4.25
|
Volume: |
963,021 |
Market Cap: |
40M |
Support:
|
1.36
1.13
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
1.72
|
MACD |
MACD(12,26):
|
0.04  |
MA(20): |
2.03  |
Signal(12,26,9): |
0.13  |
MA(100): |
1.15  |
Stochastic Oscillator |
%K(14,3):
|
9.52  |
MA(250): |
1.72  |
%D(3): |
7.72  |
Average Volume(K) |
3-Month: |
245991
|
52-Week |
High:
|
6.40 |
10-Days: |
248221 |
Low: |
0.69 |
RSI |
RSI(14):
|
48.37  |
Change(%): |
-62.8 |
Financials, Statistics and Valuation |
EPS |
-1.148 |
Return on Equity (ttm) |
-289.4 |
Shares Out. (M) |
23.12 |
EPS Est. Current Year |
-0.550 |
Return on Assets (ttm) |
-88.7 |
Shares Float (M) |
8.76 |
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.09 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
32.62 |
Forward EPS |
-2.280 |
Gross Profit (p.s.) |
0.053 |
Shares Short (K) |
533 |
Book Value (p.s.) |
0.020 |
EBITDA (p.s.) |
-0.831 |
P/E |
-1.49 |
Sales Per Share |
0.021 |
Qtrly Earnings Growth |
0.00 |
P/BV |
85.50 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.75 |
P/S |
79.55 |
Operating Margin |
-3915.29 |
Levered Free Cash Flow
(M) |
-14.42 |
P/CF |
-1.74 |
|
|
|
|
|